Thomas V Riley

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Topics

Silver Nanoparticles

Antimicrobial Resistance

Wastewater Treatment

Irritable Bowel Syndrome

Top Venues

Microbiology resource announcements

Emerging microbes & infections

Journal of clinical microbiology

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Korakrit Imwattana, Niraj Shivaperumal, Teera Leepattarakit, Pattarachai Kiratisin, Daniel R Knight, Thomas V Riley
The Brief Case: a White-Colony-Producing Clostridioides difficile Ribotype 020 Strain. Journal of clinical microbiology 61 (6) (2023)
Sarah Larcombe, Galain C Williams, Jacob Amy, Su Chen Lim, Thomas V Riley, Anthony Muleta, Adele A Barugahare, David R Powell, Priscilla A Johanesen, Allen C Cheng, Anton Y Peleg, Dena Lyras
A genomic survey of Clostridioides difficile isolates from hospitalized patients in Melbourne, Australia. Microbiology spectrum (2023)
Karla Cautivo-Reyes, Daniel R Knight, Deborah Bowie, Benjamin Moreira-Grez, Andrew S Whiteley, Thomas V Riley
Biogeographic distribution and molecular epidemiology of Clostridioides ( Clostridium ) difficile in Western Australian soils. Applied and environmental microbiology (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Natasza M R Hain-Saunders, Daniel R Knight, Mieghan Bruce, David P Byrne, Thomas V Riley
Genomic Analysis of Clostridioides difficile Recovered from Horses in Western Australia. Microorganisms 11 (7) (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements (2023)
Deirdre A Collins, Thomas V Riley
Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile. Letters in applied microbiology 75 (3) (2022)
Nirajmohan Shivaperumal, Daniel R Knight, Korakrit Imwattana, Grace O Androga, Barbara J Chang, Thomas V Riley
Esculin hydrolysis negative and TcdA-only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia. Journal of applied microbiology 133 (3) (2022)
Jessica M Chisholm, Papanin Putsathit, Thomas V Riley, Su Chen Lim
Spore-Forming Clostridium ( Clostridioides ) difficile in Wastewater Treatment Plants in Western Australia. Microbiology spectrum (2022)
Su Chen Lim, Natasza M R Hain-Saunders, Korakrit Imwattana, Papanin Putsathit, Deirdre A Collins, Thomas V Riley
Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole-genome sequencing. Environmental microbiology (2021)
Korakrit Imwattana, Daniel R Knight, Thomas V Riley
Can sequencing improve the diagnosis and management of Clostridioides difficile infection? Expert review of molecular diagnostics 21 (5) (2021)
Su Chen Lim, Deirdre A Collins, Korakrit Imwattana, Daniel R Knight, Sicilia Perumalsamy, Natasza M R Hain-Saunders, Papanin Putsathit, David Speers, Thomas V Riley
Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the community. Journal of applied microbiology (2021)
Daniel R Knight, Korakrit Imwattana, Brian R Kullin, Enzo Guerrero-Araya, Daniel Paredes-Sabja, Xavier Didelot, Kate E Dingle, David W Eyre, César Rodríguez, Thomas V Riley
Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy. eLife 10 (2021)
Muni Kumar Mahadari, Sreenu Jennepalli, Andrew J Tague, Papanin Putsathit, Melanie L Hutton, Katherine A Hammer, Daniel R Knight, Thomas V Riley, Dena Lyras, Paul A Keller, Stephen G Pyne
Cationic Peptidomimetic Amphiphiles Having a N-Aryl- or N-Naphthyl-1,2,3-Triazole Core Structure Targeting Clostridioides (Clostridium) difficile: Synthesis, Antibacterial Evaluation, and an In Vivo C. difficile Infection Model. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Yun Luo, Elaine Cheong, Qiao Bian, Deirdre A Collins, Julian Ye, Jeong Hwan Shin, Wing Cheong Yam, Tohru Takata, Xiaojun Song, Xianjun Wang, Mini Kamboj, Thomas Gottlieb, Jianmin Jiang, Thomas V Riley, Yi-Wei Tang, Dazhi Jin
Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region. Emerging microbes & infections 8 (1) (2020)
Korakrit Imwattana, Papanin Putsathit, Teera Leepattarakit, Pattarachai Kiratisin, Thomas V Riley
Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand. Journal of clinical microbiology 58 (9) (2020)
Stacey Hong, Papanin Putsathit, Narelle George, Christine Hemphill, Peter G Huntington, Tony M Korman, Despina Kotsanas, Monica Lahra, Rodney McDougall, Casey V Moore, Graeme R Nimmo, Louise Prendergast, Jennifer Robson, Lynette Waring, Michael C Wehrhahn, Gerhard F Weldhagen, Richard M Wilson, Thomas V Riley, Daniel R Knight
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018. Journal of clinical microbiology 58 (11) (2020)
Su Chen Lim, Daniel R Knight, Peter Moono, Niki F Foster, Thomas V Riley
Clostridium difficile in soil conditioners, mulches and garden mixes with evidence of a clonal relationship with historical food and clinical isolates. Environmental microbiology reports 12 (6) (2020)
Nirajmohan Shivaperumal, Barbara J Chang, Thomas V Riley
High Prevalence of Clostridium difficile in Home Gardens in Western Australia. Applied and environmental microbiology 87 (1) (2020)
Korakrit Imwattana, Daniel R Knight, Brian Kullin, Deirdre A Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V Riley
Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. Emerging microbes & infections 8 (1) (2019)
Korakrit Imwattana, Daniel R Knight, Brian Kullin, Deirdre A Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V Riley
Antimicrobial resistance in Clostridium difficile ribotype 017. Expert review of anti-infective therapy 18 (1) (2019)
Nitin Kumar, Hilary P Browne, Elisa Viciani, Samuel C Forster, Simon Clare, Katherine Harcourt, Mark D Stares, Gordon Dougan, Derek J Fairley, Paul Roberts, Munir Pirmohamed, Martha R J Clokie, Mie Birgitte Frid Jensen, Katherine R Hargreaves, Margaret Ip, Lothar H Wieler, Christian Seyboldt, Torbjörn Norén, Thomas V Riley, Ed J Kuijper, Brendan W Wren, Trevor D Lawley
Adaptation of host transmission cycle during Clostridium difficile speciation. Nature genetics 51 (9) (2019)
Deirdre A Collins, Kyung Mok Sohn, Yuan Wu, Kentaro Ouchi, Yoshikazu Ishii, Briony Elliott, Thomas V Riley, Kazuhiro Tateda, null null
Clostridioides difficile infection in the Asia-Pacific region. Emerging microbes & infections 9 (1) (2019)
Deirdre A Collins, Thomas V Riley
Clostridium difficile in Asia: Opportunities for One Health Management. Tropical medicine and infectious disease 4 (1) (2018)
Niloufar Roshan, Thomas V Riley, Daniel R Knight, Katherine A Hammer
Effect of natural products on the production and activity of Clostridium difficile toxins in vitro. Scientific reports 8 (1) (2018)
Nikki Y T Man, Daniel R Knight, Scott G Stewart, Allan J McKinley, Thomas V Riley, Katherine A Hammer
Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound. Scientific reports 8 (1) (2018)
Alan M McGovern, Grace O Androga, Daniel R Knight, Mark W Watson, Briony Elliott, Niki F Foster, Barbara J Chang, Thomas V Riley
Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027. PloS one 12 (11) (2017)